Literature DB >> 26779858

The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.

Ann Swillen1.   

Abstract

PURPOSE OF REVIEW: The 22q11.2 deletion syndrome (velo-cardio-facial syndrome or DiGeorge syndrome) is the most common known contiguous gene deletion syndrome, and is associated with neurodevelopmental problems and diverse neuropsychiatric disorders across the life span. In this review, we discuss the wide variability in intelligence, the developmental phenotypic transitions regarding cognitive development (intelligence) from preschool to adolescence, and the importance of understanding these cognitive trajectories in 22q11.2 deletion syndrome for care/management and research. RECENT
FINDINGS: Longitudinal data on the cognitive development of children and adolescents with 22q11.2 deletion syndrome reveal divergent cognitive trajectories. A decline in verbal intelligence quotient precedes the onset of psychosis in 22q11.2 deletion syndrome.
SUMMARY: Understanding these cognitive trajectories is important since it can guide clinicians to develop adequate support, tailored remediation, and psychiatric care and individualized follow-up.

Entities:  

Mesh:

Year:  2016        PMID: 26779858      PMCID: PMC5414032          DOI: 10.1097/YCO.0000000000000231

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  39 in total

1.  Cognitive development in children with 22q11.2 deletion syndrome.

Authors:  Sasja N Duijff; Petra W J Klaassen; Henriette F N Swanenburg de Veye; Frits A Beemer; Gerben Sinnema; Jacob A S Vorstman
Journal:  Br J Psychiatry       Date:  2012-06       Impact factor: 9.319

Review 2.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

3.  Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.

Authors:  R E Gur; J J Yi; D M McDonald-McGinn; S X Tang; M E Calkins; D Whinna; M C Souders; A Savitt; E H Zackai; P J Moberg; B S Emanuel; R C Gur
Journal:  Mol Psychiatry       Date:  2014-01-21       Impact factor: 15.992

4.  Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.

Authors:  Laurens J M Evers; Leopold M G Curfs; Jaap A Bakker; Erik Boot; Fabiana da Silva Alves; Nico Abeling; Jörgen Bierau; Marjan Drukker; Therese A M J van Amelsvoort
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-08       Impact factor: 5.176

5.  Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.

Authors:  Lena Niklasson; Peder Rasmussen; Sólveig Oskarsdóttir; Christopher Gillberg
Journal:  Dev Med Child Neurol       Date:  2002-01       Impact factor: 5.449

Review 6.  Velo-cardio-facial syndrome: a distinctive behavioral phenotype.

Authors:  R J Shprintzen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

7.  22q11.2DS deletion syndrome: developmental milestones in infants and toddlers.

Authors:  Nancy J Roizen; Kevin M Antshel; Wanda Fremont; Nuria AbdulSabur; Anne Marie Higgins; Robert J Shprintzen; Wendy R Kates
Journal:  J Dev Behav Pediatr       Date:  2007-04       Impact factor: 2.225

8.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

9.  Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome.

Authors:  Therese van Amelsvoort; Jayne Henry; Robin Morris; Michael Owen; Don Linszen; Kieran Murphy; Declan Murphy
Journal:  Schizophr Res       Date:  2004-10-01       Impact factor: 4.939

10.  Psychopathology and cognition in children with 22q11.2 deletion syndrome.

Authors:  Maria Niarchou; Stanley Zammit; Stephanie H M van Goozen; Anita Thapar; Hayley M Tierling; Michael J Owen; Marianne B M van den Bree
Journal:  Br J Psychiatry       Date:  2013-10-10       Impact factor: 9.319

View more
  6 in total

Review 1.  Developmental Support for Infants With Genetic Disorders.

Authors:  Monica H Wojcik; Jane E Stewart; Susan E Waisbren; Jonathan S Litt
Journal:  Pediatrics       Date:  2020-05       Impact factor: 7.124

Review 2.  Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

3.  Psychiatric disorders and autism in young children with 22q11.2 deletion syndrome compared to children with idiopathic autism.

Authors:  Yaffa Serur; Dafna Sofrin Frumer; Keren Daon; Dolly Sobol-Havia; Ronnie Weinberger; Cory Shulman; Doron Gothelf
Journal:  Eur Psychiatry       Date:  2018-11-16       Impact factor: 5.361

Review 4.  Neurodevelopmental outcome in 22q11.2 deletion syndrome and management.

Authors:  Ann Swillen; Edward Moss; Sasja Duijff
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

Review 5.  Overview of Social Cognitive Dysfunctions in Rare Developmental Syndromes With Psychiatric Phenotype.

Authors:  Aurore Morel; Elodie Peyroux; Arnaud Leleu; Emilie Favre; Nicolas Franck; Caroline Demily
Journal:  Front Pediatr       Date:  2018-05-03       Impact factor: 3.418

Review 6.  Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.

Authors:  Małgorzata Karbarz
Journal:  Genes (Basel)       Date:  2020-08-22       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.